Wednesday, 5 June 2013

HI Buddy New Delhi: Cadila Healthcare on Wednesday said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes for launch in the country. Drug Controller

New Delhi: Cadila Healthcare on Wednesday said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes for launch in the country. Drug Controller



via HI Buddy http://swagraam.com/rahulb/link-id_3371/
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)